Clinical Outcomes according to the Achievement of Target Low Density Lipoprotein-Cholesterol in Patients with Acute...

Area of Science:

• Cardiology
• Interventional Cardiology
• Lipid Metabolism

Background:

• Acute myocardial infarction (AMI) is a critical cardiovascular event.
• Percutaneous coronary intervention (PCI) is a common treatment for AMI.
• The impact of achieving target low-density lipoprotein-cholesterol (LDL-C) levels on AMI patient outcomes post-PCI is not well-established.

Purpose of the Study:

• To investigate whether achieving a target LDL-C level (below 70 mg/dL) in AMI patients undergoing PCI is associated with improved clinical outcomes.
• To compare the incidence of major adverse cardiac events (MACE) between patients who achieved target LDL-C and those who did not.

Main Methods:

• A large-scale, prospective, multicenter Korean Myocardial Infarction (KorMI) registry was utilized, enrolling 13473 AMI patients.
• Propensity score matching was applied to 1292 patients (646 LDL-C achievers vs. 646 non-achievers) to balance baseline characteristics.
• The primary endpoint was the composite of 1-year MACE, including cardiac death, recurrent MI, target lesion revascularization (TLR), and coronary artery bypass grafting.

Main Results:

• After propensity score matching, baseline characteristics were similar between the target LDL-C achiever and non-achiever groups.
• No significant differences were observed in the incidence of cardiac death (0.5% vs. 0.5%), recurrent MI (1.1% vs. 0.8%), TLR (5.0% vs. 4.5%), MACE (6.5% vs. 5.9%), or stent thrombosis (2.5% vs. 1.9%) between the groups.
• The p-values for all primary and secondary endpoints indicated no statistically significant differences.

Conclusions:

• Achievement of target LDL-C levels (below 70 mg/dL) in AMI patients undergoing PCI, as assessed by propensity score matching, did not lead to significantly better clinical outcomes.
• These findings suggest that simply reaching a specific LDL-C threshold may not be sufficient to improve major adverse cardiac events in this patient population.
• Further research may be needed to explore other factors influencing clinical outcomes in AMI patients post-PCI.